Useless power [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2012-04-02 18:19 (5197 d 01:58 ago) – Posting: # 8367
Views: 5,242

Dear Kotu!

❝ How to calculate Power in Partial/fully replicate study design based on FDA's Progesterone guidance SAS Program. Whether power is required are not in replicate study designs.


Power is not mentioned anywhere in the code with good reasons. Retrospective (aka a posteriori, post-hoc) power calculations are futile in bioequivalence studies (of any design). Either the study passed or not.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
156 visitors (0 registered, 156 guests [including 28 identified bots]).
Forum time: 20:17 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5